In September, the FDA began posting on its web site a list of drugs it is investigating for adverse side effects. The new program is required by Congress, in response to public demand for more transparency in the drug investigation process. Here, Legal Briefs' Amy Yeargan talks about the program. Ranked 2.64 / 5 162 views 0 comments
Click here to watch the video (02:16)
Submitted By: beasleyallen
Tags:
FDA Beasley Allen Alabama Attorneys Lawsuits Drugs
Categories: News & Events People & Stories
